Anthony Harrelson is nothing short of an expert when it comes to dealing with infectious and deadly diseases. He is currently the Chief Executive Officer and Founder of White Oak Industries Inc., which is a biopharmaceutical company devoted to the development of advanced immunotherapies. Their goal is to enter into fields that suffer from unmet medical needs and develop vaccines that will help people suffering from infectious diseases all over the world. They are dedicated to fighting diseases like Ebola and HIV, which are still plaguing millions of people in developed and undeveloped countries alike all over the world. However, they are using advancements in biotechnology, namely stem cells, in order to solve the many problems associate with creating vaccines for deadly viruses.
HIV is an infectious disease that has been eluding doctors and medical professionals alike for decades. The disease is difficult to treat because it lives within parts of the body that can be negatively affected by the treatments doctors use to fight the disease. Not only does it live and hide within parts of the body that can be negatively affected by treatments, but it also constantly mutates as it is spread from person to person. This makes it incredibly hard not only to treat, but to also develop a vaccination for the elusive disease. However, through the use of biotechnology companies like White Oak Industries Inc. have been able to use stem cells in order to help better treat and develop possible vaccinations for the disease.
At White Oak Industries Inc., they are using stem cells in order to solve the problems that the HIV virus causes medical professionals in terms of treatment and vaccinations. They use immunotherapies based on each patient’s specific immune system and the disease they are suffering from. Since no HIV virus is exactly the same for every infected person, it is important to use the body to target the specific cells invaded by the disease itself. Through this type of treatment, they can more easily adapt to the mutating virus. This type of RNA interference is one of the most important developments within the field of biomedical science and has opened the door for more advanced immunotherapies.
Anthony Harrelson is dedicated to helping his company solve the HIV vaccination and treatment problems. His highly advanced immunotherapies could be the difference between spreading the disease and stopping it in its tracks.
HIV is an infectious disease that has been eluding doctors and medical professionals alike for decades. The disease is difficult to treat because it lives within parts of the body that can be negatively affected by the treatments doctors use to fight the disease. Not only does it live and hide within parts of the body that can be negatively affected by treatments, but it also constantly mutates as it is spread from person to person. This makes it incredibly hard not only to treat, but to also develop a vaccination for the elusive disease. However, through the use of biotechnology companies like White Oak Industries Inc. have been able to use stem cells in order to help better treat and develop possible vaccinations for the disease.
At White Oak Industries Inc., they are using stem cells in order to solve the problems that the HIV virus causes medical professionals in terms of treatment and vaccinations. They use immunotherapies based on each patient’s specific immune system and the disease they are suffering from. Since no HIV virus is exactly the same for every infected person, it is important to use the body to target the specific cells invaded by the disease itself. Through this type of treatment, they can more easily adapt to the mutating virus. This type of RNA interference is one of the most important developments within the field of biomedical science and has opened the door for more advanced immunotherapies.
Anthony Harrelson is dedicated to helping his company solve the HIV vaccination and treatment problems. His highly advanced immunotherapies could be the difference between spreading the disease and stopping it in its tracks.
No comments:
Post a Comment